Financhill
Sell
44

TLSI Quote, Financials, Valuation and Earnings

Last price:
$5.25
Seasonality move :
7.96%
Day range:
$5.30 - $5.51
52-week range:
$3.42 - $7.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.47x
P/B ratio:
--
Volume:
92.5K
Avg. volume:
189.5K
1-year change:
5.43%
Market cap:
$271.8M
Revenue:
$29.4M
EPS (TTM):
-$2.02

Earnings Data

Next earnings date for TLSI
Mar 26
2026
Most recent earnings per share
-$0.96
Missed by $0.79
(Nov 13/2025)
Consensus Estimate
-$0.17
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TLSI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $13.6M -- -- -- --
03/26/2026 Q4 $13.2M -- -- -$0.13 --
11/13/2025 Q3 $11.8M $11.6M -$0.96 -$0.17 -$0.79
08/12/2025 Q2 $10.7M $11.2M -$0.27 -$0.22 -$0.05
05/15/2025 Q1 $9M $9.2M -$0.39 -$0.20 -$0.19
03/27/2025 Q4 $8.2M $8.3M -$0.40 -$0.35 -$0.05
11/14/2024 Q3 $7.4M $7.3M -$0.12 -$0.37 $0.24
08/15/2024 Q2 $6.9M $7.4M -$0.21 -- --
05/15/2024 Q1 $6.2M $6.5M -$0.60 -$0.72 $0.12
02/29/2024 Q4 $5.5M $5.7M -$1.57 -$0.69 -$0.88
11/14/2023 Q3 -- $5.2M -$0.14 -- --
06/30/2023 Q2 -- $4.6M -$0.61 -- --
03/31/2023 Q1 -- $3M -$0.57 -- --
12/31/2022 Q4 -- $3.2M -$75.01 -- --
09/30/2022 Q3 -- $3.9M -$25.95 -- --
06/30/2022 Q2 -- -- $0.08 -- --
03/31/2022 Q1 -- -- $0.09 -- --
12/31/2021 Q4 -- -- $0.09 -- --
09/30/2021 Q3 -- -- $0.06 -- --
06/30/2021 Q2 -- -- $0.01 -- --
03/31/2021 Q1 -- -- -$0.01 -- --
09/30/2020 Q3 -- -- -- -- --

TriSalus Life Sciences, Inc. Earnings Questions

  • How Much did TriSalus Life Sciences, Inc. Generate in Revenue Last Quarter?

    TriSalus Life Sciences, Inc. reported $11.6M worth of top line sales in its most recent quarter.

  • Did TriSalus Life Sciences, Inc. Beat Earnings Last Quarter?

    TriSalus Life Sciences, Inc. announced earnings per share of -$0.96 which represents a miss of analyst forecast a -$0.17 per share.

  • Is TriSalus Life Sciences, Inc. Profitable?

    TriSalus Life Sciences, Inc. reported $9.7M that represents $0.22 per share over the last quarter.

  • What is the Analyst Consensus for TriSalus Life Sciences, Inc. EPS Next Year?

    TriSalus Life Sciences, Inc.'s earnings are forecast to decrease from -$1.31 per share to -$0.50 per share next year representing a decrease of -61.89%.

  • When is TriSalus Life Sciences, Inc.'s Earnings Date?

    TriSalus Life Sciences, Inc.'s next earnings date is March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Is Palantir Stock Going to Crash?
Is Palantir Stock Going to Crash?

AI and data analytics major Palantir (NASDAQ:PLTR) has become something…

Why Did AMD Stock Go Up?
Why Did AMD Stock Go Up?

Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
47
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
70
BNAI alert for Jan 26

Brand Engagement Network, Inc. [BNAI] is up 279.19% over the past day.

Buy
56
INTC alert for Jan 26

Intel Corp. [INTC] is down 5.77% over the past day.

Buy
64
BNR alert for Jan 26

Burning Rock Biotech Ltd. [BNR] is up 1.45% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock